HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 192 filers reported holding HAEMONETICS CORP in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,255,901 | +7.3% | 15,181 | +10.7% | 0.01% | +16.7% |
| Q1 2024 | $1,169,983 | +26.4% | 13,708 | +26.6% | 0.01% | +9.1% |
| Q4 2023 | $925,575 | -13.4% | 10,824 | -9.2% | 0.01% | -21.4% |
| Q3 2023 | $1,068,360 | +14.8% | 11,926 | +9.1% | 0.01% | +16.7% |
| Q2 2023 | $930,816 | +49.2% | 10,933 | +52.8% | 0.01% | -7.7% |
| Q3 2020 | $624,000 | -46.0% | 7,154 | -44.5% | 0.01% | -48.0% |
| Q2 2020 | $1,155,000 | -20.4% | 12,894 | -11.5% | 0.02% | -30.6% |
| Q1 2020 | $1,451,000 | -17.1% | 14,562 | -4.4% | 0.04% | +9.1% |
| Q4 2019 | $1,750,000 | -22.5% | 15,232 | -14.9% | 0.03% | -26.7% |
| Q3 2019 | $2,257,000 | +87.8% | 17,895 | +79.1% | 0.04% | +80.0% |
| Q2 2019 | $1,202,000 | +115.4% | 9,989 | -24.6% | 0.02% | +13.6% |
| Q4 2013 | $558,000 | -32.6% | 13,246 | -36.2% | 0.02% | -38.9% |
| Q3 2013 | $828,000 | +1.8% | 20,760 | +5.5% | 0.04% | -2.7% |
| Q2 2013 | $813,000 | – | 19,672 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Black Creek Investment Management Inc. | 1,014,941 | $33,077,000 | 3.62% |
| Camber Capital Management LP | 1,202,000 | $39,173,000 | 3.07% |
| AMERICAN CAPITAL MANAGEMENT INC | 718,380 | $23,412,000 | 2.76% |
| Van Berkom & Associates Inc. | 1,258,322 | $41,009,000 | 2.31% |
| SNYDER CAPITAL MANAGEMENT L P | 1,222,547 | $39,843,000 | 2.07% |
| KESTREL INVESTMENT MANAGEMENT CORP | 441,250 | $14,380,000 | 1.78% |
| STONE RUN CAPITAL, LLC | 33,740 | $1,100,000 | 0.80% |
| HERMES INVESTMENT MANAGEMENT LTD | 728,123 | $23,730,000 | 0.75% |
| ANCHOR CAPITAL ADVISORS LLC | 1,119,060 | $36,470,000 | 0.73% |
| Netols Asset Management, Inc. | 137,267 | $4,473,000 | 0.72% |